Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  The Lancet

• Publication date

  2004-03-06

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(04)15690-0PMID 15016485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utility of TICS‐M for the assessment of cognitive function in older adults

  2003cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial.

  2003cited by this paper
• Statin‐Associated Memory Loss: Analysis of 60 Case Reports and Review of the Literature

  2003cited by this paper
• Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis

  2003cited by this paper
• Cholesterol, coronary heart disease, and stroke in the Asia Pacific region.

  2003cited by this paper
• Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

  2003cited by this paper
• Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.

  2002cited by this paper
• Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

  2002cited by this paper
• Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.

  2002cited by this paper
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

  2002cited by this paper
• Statins and risk of polyneuropathy: A case-control study

  2002cited by this paper
• Treatment with Atorvastatin to the National Cholesterol Educational Program Goal Versus 'Usual' Care in Secondary Coronary Heart Disease Prevention

  2002cited by this paper
• Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.

  2001cited by this paper
• Statins for stroke prevention?

  2001cited by this paper
• Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

  2001cited by this paper
• Reduction of Stroke Events With Pravastatin: The Prospective Pravastatin Pooling (PPP) Project

  2001cited by this paper
• Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association.

  2001cited by this paper
• Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction

  2001cited by this paper
• Pravastatin therapy and the risk of stroke.

  2000cited by this paper
• Statins and the risk of dementia.

  2000cited by this paper
• Cholesterol Reduction and Stroke Occurrence: An Overview of Randomized Clinical Trials

  2000cited by this paper
• MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience.

  1999cited by this paper
• Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

  1999cited by this paper
• Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association.

  1999cited by this paper
• Blood pressure, cholesterol, and stroke in eastern Asia. Eastern Stroke and Coronary Heart Disease Collaborative Research Group.

  1998cited by this paper
• Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

  1998cited by this paper
• Blood pressure, cholesterol, and stroke in eastern Asia

  1998cited by this paper
• Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group.

  1998cited by this paper
• The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts.

  1997cited by this paper
• Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

  1997cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia

  1995cited by this paper
• Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration.

  1995cited by this paper
• An overview of trials of cholesterol lowering and risk of stroke.

  1995cited by this paper
• Stroke incidence, case fatality, and mortality in the WHO MONICA project. World Health Organization Monitoring Trends and Determinants in Cardiovascular Disease.

  1995cited by this paper
• Serum total cholesterol and mortality. Confounding factors and risk modification in Japanese-American men.

  1995cited by this paper
• Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II)

  1995cited by this paper
• Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

  1995cited by this paper
• Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration.

  1995cited by this paper
• Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

  1994cited by this paper
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

  1994cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Report of the Conference on Low Blood Cholesterol: Mortality Associations

  1992cited by this paper
• Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

  1991cited by this paper
• Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

  1989cited by this paper
• Interobserver agreement for the assessment of handicap in stroke patients.

  1989cited by this paper
• Serum cholesterol, other risk factors, and cardiovascular disease in a Japanese cohort.

  1984cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial.

  1975cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• The effects of cholesterol-lowering drugs on neurocognitive function: systematic review and meta analysis.

  2026cites this paper
• Polygenic risk for white matter hyperintensities is associated with early cerebrovascular events partly through hemodynamic measures in cognitively unimpaired middle-aged and older adults with low cardiovascular risk

  2026cites this paper
• LDL-Cholesterol Lowering Agents (Statins and PCSK9 Inhibitors) and the Risk of Intracerebral Hemorrhage: A Network Meta-Analysis.

  2025cites this paper
• High-dose statins for the prevention of recurrent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials

  2025cites this paper
• The role of 25-hydroxycholesterol in the pathophysiology of brain vessel dysfunction associated with infection and cholesterol dysregulation

  2025cites this paper
• Association between blood triglycerides and stroke-associated pneumonia: a prospective cohort study

  2025cites this paper
• Type 2 statin use increased perioperative blood loss in primary reverse total shoulder arthroplasty

  2025cites this paper
• Non-Anticoagulation Strategies Aimed at Primary Stroke Prevention in Nascent Atrial Fibrillation

  2025cites this paper
• A bibliometric analysis of mechanisms and linkage studies on neurological disorders and statins over the past 20 years

  2025cites this paper
• Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2025

  2025cites this paper
• Cryptogenic Stroke and Migraine: Using Probabilistic Independence and Machine Learning to Uncover Latent Sources of Disease from the Electronic Health Record

  2025cites this paper
• Statin use is associated with reduced risk of incident intracerebral hemorrhage: A prospective population-based cohort study

  2025cites this paper
• Secondary prevention using a statin with or without aspirin among Ghanaian intracerebral hemorrhage survivors: A feasibility randomized trial

  2025cites this paper
• Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP).

  2025cites this paper
• Strategic Lowering of LDL-Cholesterol Post Ischemic Stroke: Identifying Optimal Targets, Timing, and Therapeutic Approaches

  2025cites this paper
• Association Between Statin Use and Psoriasis in Patients with Dyslipidemia: A Korean National Health Screening Cohort Study

  2024cites this paper
• Statin Therapy for Secondary Prevention in Ischemic Stroke Patients With Cerebral Microbleeds.

  2024cites this paper
• Statins during Anticoagulation for Emergency Life-Threatening Venous Thromboembolism: A Review

  2024cites this paper
• Statins did not reduce the frequency of exacerbations in individuals with COPD and cardiovascular comorbidities in the COSYCONET cohort

  2024cites this paper
• Leukoaraiosis: Epidemiology, Imaging, Risk Factors, and Management of Age-Related Cerebral White Matter Hyperintensities

  2024cites this paper
• Risk of Hemorrhagic Stroke among Patients Treated with High-Intensity Statins versus Pitavastatin-Ezetimibe: A Population Based Study.

  2024cites this paper
• Brazilian Angiology and Vascular Surgery Society Guidelines for the treatment of extracranial cerebrovascular disease

  2024cites this paper
• European stroke organisation (ESO) guideline on cerebral small vessel disease, part 2, lacunar ischaemic stroke

  2024cites this paper
• Projected Changes in Statin and Antihypertensive Therapy Eligibility With the AHA PREVENT Cardiovascular Risk Equations.

  2024cites this paper
• Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia

  2024cites this paper
• Rationale and Design of the Statin Use in Intracerebral Hemorrhage Patients (SATURN) Trial

  2024cites this paper
• Reducing the risk of atherosclerotic cardiovascular disease in people with haemophilia, the importance of primary prevention.

  2024cites this paper
• The pleiotropic effects of statins: a comprehensive exploration of neurovascular unit modulation and blood–brain barrier protection

  2024cites this paper
• Commencement of Atorvastatin and Ezetimibe Immediately in Patients Presenting with Acute Coronary Syndrome

  2024cites this paper
• Aggressive LDL-C Lowering and the Brain: Impact on Risk for Dementia and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association

  2023cites this paper
• Population-Attributable Risk Fractions for Antiplatelets and Anticoagulants in Spontaneous Intracranial Hemorrhages

  2023cites this paper
• Beyond antithrombotics: recent advances in pharmacological risk factor management for secondary stroke prevention

  2023cites this paper
• Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review

  2023cites this paper
• The Effect of Simvastatin on the Dynamics of NF-κB-Regulated Neurodegenerative and Neuroprotective Processes in the Acute Phase of Ischemic Stroke

  2023cites this paper
• [Does aspirin have a place in primary cardiovascular prevention by the polypill ? Simulation study on a realistic virtual population].

  2023cites this paper
• Secondary Ischemic Stroke Prevention

  2023cites this paper
• Statin Use and Stroke Rate in Older Adults With Atrial Fibrillation: A Population‐Based Cohort Study

  2023cites this paper
• Effects of Serum Cholesterol on Severity of Stroke and Dosage of Statins on Functional Outcome in Acute Ischemic Stroke

  2023cites this paper
• Influence of atherosclerotic burden on adult patients with ischemic moyamoya disease: combined analysis of two prospective cohorts

  2023cites this paper
• Stroke risk management in carotid atherosclerotic disease: A Clinical Consensus Statement of the ESC Council on Stroke and the ESC Working Group on Aorta and Peripheral Vascular Diseases.

  2023cites this paper
• The efficacy of statins in the treatment of rheumatoid arthritis: A systematic review and meta-analysis

  2023cites this paper
• Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease

  2023cites this paper
• Statin's role on blood pressure levels: Meta‐analysis based on randomized controlled trials

  2023cites this paper
• Circulating biomarkers in familial cerebral cavernous malformation

  2023cites this paper
• HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.

  2023cites this paper
• Comparison of three definition of the metabolic syndrome in Korean patients with acute ischemic stroke: a retrospective study (Republic of Korea)

  2023cites this paper
• Low-density Lipoprotein Cholesterol Reduction Therapies for Secondary Prevention in Patients with Stroke: A Network Meta-analysis

  2023cites this paper
• What are the benefits and drawbacks of statins in carotid artery disease? A perspective review

  2023cites this paper
• Lipid management in ischaemic stroke or transient ischaemic attack in China: result from China National Stroke Registry III

  2023cites this paper
• Statins Effects on Blood Clotting: A Review

  2023cites this paper
• Dyslipidemias and stroke prevention: Recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology.

  2022cites this paper
• The Association between Low Levels of Low Density Lipoprotein Cholesterol and Intracerebral Hemorrhage: Cause for Concern?

  2022cites this paper
• Auditing integrated stroke care to support quality improvement activities: development of a peer-to-peer audit framework

  2022cites this paper
• Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention

  2022cites this paper
• Cardiovascular Risk Factors Drive Impaired Fasting Glucose to Type 2 Diabetes: Findings After a 9-Year Follow-Up in the PURE Study in Poland.

  2022cites this paper
• Statin use is associated with lower risk of dementia in stroke patients: a community-based cohort study with inverse probability weighted marginal structural model analysis

  2022influential citation
• Prevalence and Effects of High-Intensity Statins for Japanese Patients Presenting With Acute Coronary Syndrome　- A Post Hoc Secondary Analysis of STOPDAPT-2 ACS.

  2022cites this paper
• Risk of stroke in genetically verified familial hypercholesterolemia: A prospective matched cohort study.

  2022cites this paper
• Weight loss in a cardiovascular trial population identifies people at future risk of dementia

  2022cites this paper
• Association Between Statin Use and Intracerebral Hemorrhage Location

  2022cites this paper
• Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)

  2022cites this paper
• Association of cognitive function, depression, and quality of sleep with statins among oldest-old individuals

  2022cites this paper
• Modifiable Risk Factors for the Occurrence of Ipsilateral Ischemic Events After Carotid Endarterectomy Beyond the Perioperative Period.

  2022cites this paper
• Management of Dyslipidemia after Stroke

  2022cites this paper
• Stains therapy and the risk of all bleeding and intracranial hemorrhage: A meta‐analysis of randomized controlled studies

  2022cites this paper
• Genetically predicted on-statin LDL response is associated with higher intracerebral haemorrhage risk.

  2022cites this paper
• Association of Lipids, Lipoproteins, and Apolipoproteins with Stroke Subtypes in an International Case Control Study (INTERSTROKE)

  2022cites this paper
• Lipids, Apolipoproteins, Statins, and Intracerebral Hemorrhage: A Mendelian Randomization Study

  2022cites this paper
• Association of Long-term Statin Use With the Risk of Intracerebral Hemorrhage

  2022cites this paper
• European society for vascular surgery (ESVS) 2023 Clinical practice guidelines on the management of atherosclerotic carotid and vertebral artery disease.

  2022cites this paper
• Tumor-Suppressive Effect of Metformin via the Regulation of M2 Macrophages and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment of Colorectal Cancer

  2022cites this paper
• Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk

  2022cites this paper
• Hypolipidemic agents in the secondary prevention of the stroke

  2022cites this paper
• Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease: It Is About Time and Timing.

  2022cites this paper
• European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack

  2022influential citation
• Statin Therapy for Preventing Recurrent Stroke in Patients with Ischemic Stroke: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Cohort Studies

  2022cites this paper
• Beyond Lipid-Lowering: Effects of Statins on Cardiovascular and Cerebrovascular Diseases and Cancer

  2021cites this paper
• Prognostic indicators for the onset of ischaemic versus haemorrhagic stroke in stable coronary artery disease

  2021cites this paper
• Association of major blood lipids with post‐stroke dementia: A community‐based cohort study

  2021cites this paper
• Cerebrovascular Disease and Statins

  2021cites this paper
• Practical Dyslipidemia Management in Stroke-Specific Situations

  2021cites this paper
• La prévention secondaire médicamenteuse en pathologie neuro-vasculaire a-t-elle des spécificités?

  2021cites this paper
• Intracranial Hemorrhage in the TST Trial

  2021cites this paper
• Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India.

  2021cites this paper
• Statin intolerance and new lipid-lowering treatments

  2021cites this paper
• Cognition, Statins, and Cholesterol in Elderly Ischemic Stroke Patients: A Neurologist’s Perspective

  2021cites this paper
• The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke

  2021cites this paper
• Baicalein inhibits the pharmacokinetics of simvastatin in rats via regulating the activity of CYP3A4

  2021cites this paper
• Lipid-Lowering Therapy and Hemorrhagic Stroke Risk

  2021cites this paper
• Role of White Matter Hyperintensities and Related Risk Factors in Vascular Cognitive Impairment: A Review

  2021cites this paper
• 3D carotid ultrasound in patients with a negative exercise stress test: A practical risk stratification tool

  2021cites this paper
• Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines

  2021cites this paper
• The Society for Vascular Surgery implementation document for management of extracranial cerebrovascular disease.

  2021cites this paper
• Statins After Ischemic Stroke in the Oldest

  2021cites this paper
• COVID-19 Anosmia and Lacunar Stroke

  2021cites this paper
• Statins Protect Against Thrombosis of Cannulated Radiocephalic Fistulas in Diabetic Patients.

  2021cites this paper
• Improved lipid target level attainment in patients with peripheral artery disease.

  2021cites this paper
• Dyslipidemia and Hemorrhagic Stroke

  2021cites this paper
• Current view on post‐stroke dementia

  2021cites this paper
• LDL (Low-Density Lipoprotein) Cholesterol Below 70: Good to Go!

  2020cites this paper